BioAtla has granted Context Therapeutics an exclusive global license for BA3362, a T cell-engaging antibody targeting solid ...

Daiichi Sankyo and AstraZeneca saw a dip in stock prices after announcing that their Phase III TROPION-Breast01 trial for ...

Belgian drugmaker UCB and US biotech Biogen have announced positive top-line results from the Phase III PHOENYCS GO study ...

Shares in San Diego-based inflammatory diseases specialist Ventyx Biosciences (Nasdaq: VTYX) rose 8.7% to $2.50 yesterday as ...

Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

Telix Pharmaceuticals is acquiring US-based RLS Radiopharmacies for $230 million upfront, plus $20 million in performance ...

The Association of the British Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have ...

Shares of California, USA-based precision medicines IDEAYA Biosciences were down 6.3% at $32.5 mid-morning after it revealed ...

Two new studies highlight the pharmaceutical sector's crucial role in Greece's economy. The first, The Market in Greece: ...

German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing ...

Israeli drugmaker Teva Pharmaceuticals presented new research at the European College of Neuropsychopharmacology, including ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of Hetronifly ...